Consolidated Statements of Equity (Deficit) And Noncontrolling Interest - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	AOCI Attributable to Parent [Member]	Parent [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Parent [Member]	Noncontrolling Interest [Member]	Redeemable Noncontrolling Interest In Joint Venture [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Transition adjustment related to adoption	$ 513	$ 900,795	$ (15,183)		$ (388,524)		$ (28,024)		$ 469,577		$ 287,433		$ 469,577
Beginning balance at Dec. 31, 2018	$ 513	900,795	(15,183)		(388,524)		(28,024)		469,577		287,433		469,577
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					145,794				145,794				145,794
Net loss													145,794
Net loss													(17,500)
Net loss											17,500
Adjustment of noncontrolling interest to redemption value					(68,054)				(68,054)		68,054		(68,054)
Other comprehensive income (loss), net of income taxes							2,572		2,572				2,572
Distribution from consolidated joint venture											(113,894)
Issuance of Company's common stock		282,873							282,908				$ 282,908
Issuance of Company's common stock (in shares)	35												3,500
Payment of dividends		532	(2,132)		(187,437)				(189,037)				$ (189,037)
Exercise of stock options		35							35				35
Purchase of remaining interest in consolidated joint venture		2,899							2,899		2,582		2,899
Restricted stock units and stock options surrendered	$ 1	(4,001)							(4,000)				(4,000)
Stock-based compensation expense		7,833							7,833				7,833
Ending balance at Dec. 31, 2019	549	1,185,168	(17,315)	$ 2,707	(495,514)	$ (2,707)	(28,159)		644,729		221,511		644,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Transition adjustment related to adoption	549	1,185,168	(17,315)	2,707	(495,514)	(2,707)	(28,159)		644,729		221,511		644,729
Net income (loss)					(417,391)				(417,391)	$ (956)			(417,391)
Net loss													(418,347)
Net loss													(42,474)
Net loss													(956)
Net loss											42,474
Adjustment of noncontrolling interest to redemption value					60,106				60,106		(60,106)		60,106
Other comprehensive income (loss), net of income taxes							(31,950)		(31,950)				(31,950)
Issuance of partnership units in Operating Partnership										15,472			15,472
Distribution from consolidated joint venture											(992)
Payment of dividends		135	(1,152)		(51,450)				(52,467)				(52,467)
Purchase of remaining interest in consolidated joint venture					1,500				1,500		16,970		1,500
Restricted stock units and stock options surrendered	1	(1,774)							(1,773)				(1,773)
Stock-based compensation expense		8,732							8,732				8,732
Ending balance at Dec. 31, 2020	550	1,192,261	(18,467)	(5,343)	(911,092)	2,158	(57,951)	$ (3,185)	205,301	14,516	100,969	$ (3,185)	219,817
Ending balance at Dec. 31, 2020													100,969
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Transition adjustment related to adoption	550	1,192,261	(18,467)	$ (5,343)	(911,092)	$ 2,158	(57,951)	$ (3,185)	205,301	14,516	100,969	$ (3,185)	219,817
Net income (loss)					(176,966)				(176,966)				(176,966)
Net loss													(178,300)
Net loss													(16,501)
Net loss										(1,334)			(1,334)
Net loss											(16,501)
Other comprehensive income (loss), net of income taxes							28,871		28,871				28,871
Purchase of remaining interest in consolidated joint venture		99,107							99,107		88,893		99,107
Redemption of noncontrolling interest in Operating Partnership		1,356							1,356	1,082			2,438
Reallocation of noncontrolling interest in Operating Partnership		12,259							12,259	(12,259)
Contribution to consolidated joint venture											$ 4,425
Restricted stock units and stock options surrendered	1	(3,294)			(47)				(3,340)				(3,340)
Stock-based compensation expense		12,104							12,104				12,104
Ending balance at Dec. 31, 2021	551	1,112,867	(18,467)		(1,088,105)		(29,080)		(22,234)	(159)			(22,393)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Transition adjustment related to adoption	$ 551	$ 1,112,867	$ (18,467)		$ (1,088,105)		$ (29,080)		$ (22,234)	$ (159)			$ (22,393)